NX1 — Nexalis Therapeutics Share News
0.000.00%
Last trade - 00:00- AU$2.28m
- AU$2.21m
- AU$0.99m
Brief: Nexalis Therapeutics Signs Funding Partnership With Point8 Capital To Replace Existing Facility
Brief: Nexalis Therapeutics Seeks Trading Halt
Brief: Nexalis Therapeutics Says US Policy Market Advancement Supports SRX-25 TRD Treatment
Australia's Nexalis Therapeutics gains most in over 6 months on trial approval
Brief: InhalerX Says Linlithgow Family Office Agreed To Provide A$12.6 Mln In Additional Funding
Australia's InhaleRx gains on securing funding for depression therapy SRX-25
Australia's Inhalerx set for worst session in three weeks on discounted placement
Brief: Inhalerx Seeks Trading Halt
Australia's InhaleRx rises as manufacturing begins for cancer pain trial
Australia's Inhalerx doubles in value on funding deal for clinical trials
Brief: Inhalerx Receives A$38.5M Funding To Fully Fund Clinical Development Plans
Brief: Inhalerx Sats U.S. FDA Placed Temporary Suspension On Investigational New Drug Application
Brief: Inhalerx Confirms Made Aware Of Legal Claim Against Significant Shareholder
Brief: Inhalerx Ltd Says Darryl Davies Appointed As Chief Executive Officer
Brief: Inhalerx Has Received Firm Commitments For A$1.2M Share Placement
Brief: Inhalerx Seeks Trading Halt
Australia Stock Exchange release from INHALERX : Preliminary Final Report
Australia Stock Exchange release from INHALERX : PRE_NR Ends: 10:53:21
Australia Stock Exchange release from INHALERX : PRE_NR Ends: 14:26:52